Association between SLCO1A2 genetic variation and methotrexate toxicity in human rheumatoid arthritis treatment.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of biochemical and molecular toxicology"
DOI: 10.1002/jbt.22513
Abstract: Methotrexate (MTX), one of the important disease-modifying anti-rheumatic drugs, is the first-line drug for rheumatoid arthritis (RA) treatment. However, its adverse drug effects (ADEs) often lead to the abortion of MTX therapy. Human organic anion-transporting… read more here.
Keywords: treatment; toxicity; slco1a2 genetic; mtx ... See more keywords